19156-51-5 Usage
Uses
Used in Pharmaceutical Industry:
5-Ethyl-3-thiophenecarboxylic acid is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure allows it to be a key component in the creation of various medicinal compounds.
Used in Organic Compounds Synthesis:
As a versatile building block, 5-Ethyl-3-thiophenecarboxylic acid is utilized in the synthesis of other organic compounds, broadening its applications in chemical research and development.
Used in Dye Manufacturing:
5-Ethyl-3-thiophenecarboxylic acid is used as a component in the manufacturing of dyes, capitalizing on its chemical properties to produce a range of colorants for various applications.
Used in Pesticide Production:
In the agricultural sector, 5-Ethyl-3-thiophenecarboxylic acid is employed in the production of pesticides, leveraging its chemical composition to create effective solutions for pest control.
Used in Fine Chemicals Industry:
5-ETHYL-3-THIOPHENECARBOXYLIC ACID also finds use in the manufacturing of fine chemicals, where its specific properties are harnessed for specialized applications in various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 19156-51-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,1,5 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 19156-51:
(7*1)+(6*9)+(5*1)+(4*5)+(3*6)+(2*5)+(1*1)=115
115 % 10 = 5
So 19156-51-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H8O2S/c1-2-6-3-5(4-10-6)7(8)9/h3-4H,2H2,1H3,(H,8,9)
19156-51-5Relevant academic research and scientific papers
AMIDO-THIOPHENE COMPOUNDS AND THEIR USE AS 11-BETA-HSD1 INHIBITORS
-
Page/Page column 141, (2009/07/17)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain amido-thiophene compounds that, inter alia, inhibit 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit 11β-hydroxysteroid dehydrogenase type 1; to treat disorders that are ameliorated by the inhibition of 11β-hydroxysteroid dehydrogenase type 1; to treat the metabolic syndrome, which includes disorders such as type 2 diabetes and obesity, and associated disorders including insulin resistance, hypertension, lipid disorders and cardiovascular disorders such as ischaemic (coronary) heart disease; to treat CNS disorders such as mild cognitive impairment and early dementia, including Alzheimer's disease; etc. Formula (I).
